Detalhe da pesquisa
1.
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 28(5): 433-439, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640141
2.
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.
BJU Int
; 132(5): 581-590, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488983
3.
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study.
Acta Oncol
; 62(6): 579-586, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276270
4.
Onco-nephrology: Physicians' Expectations About a New Subspecialty.
J Cancer Educ
; 38(3): 878-884, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840858
5.
Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas.
Oncologist
; 27(12): 1041-1047, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979929
6.
Standardizing immunohistochemistry methodology for evaluation of PD-1 and PDL-1 expression in upper tract urothelial carcinoma.
Can J Urol
; 28(3): 10719-10724, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129469
7.
Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
Eur Radiol
; 30(6): 3528-3537, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055950
8.
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer.
Kidney Int
; 102(4): 930-935, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964800
9.
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.
Cancer Med
; 12(3): 3172-3175, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156460
10.
Management of cancer treatments in hemodialysis patients.
Bull Cancer
; 2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36931910
11.
Incidence, management, and outcome of lung cancer in patients with long-term oxygen therapy.
Thorac Cancer
; 14(1): 36-43, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398413
12.
Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Clin Nucl Med
; 47(7): e506-e508, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426872
13.
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment.
Diagnostics (Basel)
; 12(8)2022 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010283
14.
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study.
Cancers (Basel)
; 14(7)2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406448
15.
REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study.
J Oncol
; 2022: 3449660, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35222642
16.
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
Cancers (Basel)
; 14(5)2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35267639
17.
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI.
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137651
18.
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.
Cancer Discov
; 12(10): 2280-2307, 2022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929803
19.
Case Report: Two Rare Cases of Complete Metabolic Response to Crizotinib in Patients With Rearranged ROS1 and ALK Metastatic Non-small Lung Cancer.
Front Med (Lausanne)
; 8: 691253, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34660618
20.
[Renal failure and renal symptoms associated with molecular targeted therapies in oncology]. / Insuffisance rénale et symptômes rénaux associés aux thérapies moléculaires ciblées en oncologie.
Rev Prat
; 71(2): 198-205, 2021 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-34160984